Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation
Darin2019-12-18T13:48:04-07:00Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation
Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation
Change of Name to Voyageur Pharmaceuticals Ltd., Frontier and Stock House Retained for Marketing & IR, Shares for Debt Transaction, Extension of Warrants, Resignation of Director
Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration
Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada for Registration